A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol. - Gribaleva E; Krogh NS; Prieto-Merino D; Coker B; Jackson A; Akkoc A; Birkner T; Bruninx E; Hennessy C; Chan K; Cutlar L; Farrell B; et al. (Skin health and disease, 2025)